AKT1 and breast carcinoma: Our findings are in accordance with similar studies which used platinum NPs conjugated with doxorubicin [64] and gold NPs conjugated with quercetin [65] that proved to have a significant therapeutic efficacy against breast cancer cells through PI3K/Akt signaling downregulation.